Skip to main content
See every side of every news story
Published loading...Updated

Selective Opioid Agonist Relieves Itching in Chronic Kidney Disease – Deutsches Ärzteblatt

Nanjing – The selective kappa opioid receptor agonist anrikefon can relieve itching and improve quality of life in people undergoing hemodialysis with moderate to severe pruritus. A Chinese research group reported this in the British Medical Journal (2025; DOI: 10.1136/bmj-2025-085208). The study team recruited...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Nanjing – The selective kappa opioid receptor agonist anrikefon can relieve itching and improve quality of life in people undergoing hemodialysis with moderate to severe pruritus. A Chinese research group reported this in the British Medical Journal (2025; DOI: 10.1136/bmj-2025-085208). The study team recruited...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Deutsches Ärzteblatt broke the news in on Wednesday, September 10, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal